Publications by authors named "Ervin Sinani"

Claim this Profile
T
The natural history of ALS: Baseline characteristics from a multicenter clinical cohort.
Alex Berger, Matteo Locatelli, Ximena Arcila-Londono, Ghazala Hayat, Nicholas Olney, Ervin Sinani

Amyotroph Lateral Scler Frontotemporal Degener· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS).
Megan Yerton, Allison Winter, Dario Gelevski, Grace Addy, Anthony Kostov, Ervin Sinani

Muscle Nerve· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocol.
Dario Gelevski, Grace Addy, Margot Rohrer, Caroline Cohen, Aimee Roderick, Ervin Sinani

Muscle Nerve· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An expanded access protocol of RT001 in amyotrophic lateral sclerosis-Initial experience with a lipid peroxidation inhibitor.
Megan Yerton, Allison Winter, Anthony Kostov, Cassandra Lieberman, Dario Gelevski, Ervin Sinani

Muscle Nerve· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines.
Emily G Baxi, Terri Thompson, Jonathan Li, Julia A Kaye, Ryan G Lim, Ervin Sinani

Nat Neurosci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The revised El Escorial criteria "clinically probable laboratory supported ALS"-once a promising now a superfluous category?
Nathalie Braun, Eric A Macklin, Ervin Sinani, Alexander Sherman, Markus Weber

Amyotroph Lateral Scler Frontotemporal Degener· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How common are ALS plateaus and reversals?
Richard S Bedlack, Timothy Vaughan, Paul Wicks, Jamie Heywood, Ervin Sinani

Neurology· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?
Neta Zach, David L Ennist, Albert A Taylor, Hagit Alon, Alexander Sherman, Ervin Sinani

Neurotherapeutics· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PRO-ACT database: design, initial analyses, and predictive features.
Nazem Atassi, James Berry, Amy Shui, Neta Zach, Alexander Sherman, Ervin Sinani

Neurology· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis